ImmuPharma Market Cap

ImmuPharma has a market cap or net worth of 26.20 million as of April 28, 2026. Its market cap has increased by 104.04% in one year.

Market Cap

26.20M

Enterprise Value

25.81M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

4.20

Market Cap Chart

Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 26.20M, a decrease of -27.44%. That is a compound annual growth rate of -1.58%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	28.56M	-8.38%
Dec 31, 2025	31.17M	521.13%
Dec 31, 2024	5.02M	-27.71%
Dec 29, 2023	6.94M	13.16%
Dec 30, 2022	6.13M	-62.85%
Dec 31, 2021	16.51M	-50.56%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sareum Holdings	28.99M
SkinBioTherapeutics	25.27M
Poolbeg Pharma	31.38M
Arecor Therapeutics	24.92M
Aptamer Group	20.73M
Fusion Antibodies	18.13M
IXICO	15.26M
Hemogenyx Pharmaceuticals	51.79M

Market Cap Rankings